BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15077165)

  • 1. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth.
    Guerrero C; Martín-Encabo S; Fernández-Medarde A; Santos E
    Oncogene; 2004 Jun; 23(28):4885-93. PubMed ID: 15077165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
    Martín-Encabo S; Santos E; Guerrero C
    Exp Cell Res; 2007 Nov; 313(18):3881-91. PubMed ID: 17825818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for Ras in v-Crk transformation.
    Greulich H; Hanafusa H
    Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis.
    Ohba Y; Ikuta K; Ogura A; Matsuda J; Mochizuki N; Nagashima K; Kurokawa K; Mayer BJ; Maki K; Miyazaki J; Matsuda M
    EMBO J; 2001 Jul; 20(13):3333-41. PubMed ID: 11432821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulation.
    Jacobsen K; Groth A; Willumsen BM
    Oncogene; 2002 May; 21(19):3058-67. PubMed ID: 12082537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of Rap1, antagonist to ras, by Crk-C3G].
    Hattori S; Matsuda M
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1414-21. PubMed ID: 9309134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
    Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
    Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Drosophila C3G leads to cell fate changes and overproliferation during development, mediated by the RAS-MAPK pathway and RAP1.
    Ishimaru S; Williams R; Clark E; Hanafusa H; Gaul U
    EMBO J; 1999 Jan; 18(1):145-55. PubMed ID: 9878058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Crk signaling pathway contributes to the bombesin-induced activation of the small GTPase Rap1 in Swiss 3T3 cells.
    Posern G; Rapp UR; Feller SM
    Oncogene; 2000 Dec; 19(54):6361-8. PubMed ID: 11175351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crk activation of JNK via C3G and R-Ras.
    Mochizuki N; Ohba Y; Kobayashi S; Otsuka N; Graybiel AM; Tanaka S; Matsuda M
    J Biol Chem; 2000 Apr; 275(17):12667-71. PubMed ID: 10777559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of anchorage-independent growth of human cancer cell lines by the drs gene.
    Yamashita A; Hakura A; Inoue H
    Oncogene; 1999 Aug; 18(34):4777-87. PubMed ID: 10490811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3G is required for c-Abl-induced filopodia and its overexpression promotes filopodia formation.
    Radha V; Rajanna A; Mitra A; Rangaraj N; Swarup G
    Exp Cell Res; 2007 Jul; 313(11):2476-92. PubMed ID: 17475248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway.
    Hirota T; Irie K; Okamoto R; Ikeda W; Takai Y
    Oncogene; 2005 Mar; 24(13):2229-35. PubMed ID: 15688018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3G, a guanine nucleotide exchange factor bound to adapter molecule c-Crk, has two alternative splicing forms.
    Zhai B; Huo H; Liao K
    Biochem Biophys Res Commun; 2001 Aug; 286(1):61-6. PubMed ID: 11485308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3G silencing enhances STI-571-induced apoptosis in CML cells through p38 MAPK activation, but it antagonizes STI-571 inhibitory effect on survival.
    Maia V; Sanz M; Gutierrez-Berzal J; de Luis A; Gutierrez-Uzquiza A; Porras A; Guerrero C
    Cell Signal; 2009 Jul; 21(7):1229-35. PubMed ID: 19324082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.
    Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK
    Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.